Sinovac Biotech (SVA)

3.36 -0.04  -1.18%  May 22, 2:35PM
Add to Watchlists Create an Alert

Sinovac Biotech Cash from Investing Quarterly:

-5.210M for Dec. 31, 2012
View Full Chart

Sinovac Biotech Cash from Investing Quarterly Chart

    Sinovac Biotech Historical Cash from Investing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 -5.210M
    Sept. 30, 2012 -4.322M
    June 30, 2012 -3.659M
    March 31, 2012 -2.960M
    Dec. 31, 2011 25.47M
    Sept. 30, 2011 -12.67M
    June 30, 2011 -25.43M
    March 31, 2011 -1.155M
    Dec. 31, 2010 -5.080M
    Sept. 30, 2010 -1.115M
    June 30, 2010 -3.561M
    March 31, 2010 -9.489M
    Dec. 31, 2009 -8.213M
       
    Sept. 30, 2009 -1.718M
    June 30, 2009 -0.7505M
    March 31, 2009 -1.012M
    Dec. 31, 2008 -0.6755M
    Sept. 30, 2008 -0.6127M
    June 30, 2008 -0.2934M
    March 31, 2008 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    June 30, 2006 Go Pro
    June 30, 2005 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro

    About Cash From Investing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
    Learn More

    Get data for

    SVA Cash from Investing Quarterly Benchmarks

    Companies
    Biocryst Pharmaceuticals
    Novavax -17.12M
    Hemispherx Biopharma -11.00M

    SVA Cash from Investing Quarterly Rankings

    Overall 69th percentile
    2470 of 8005
    Sector 43rd percentile
    385 of 686 in Healthcare
    Industry 35th percentile
    160 of 248 in Biotechnology

    SVA Cash from Investing Quarterly Range, Past 5 Years

    Minimum -25.43M Jun 2011
    Maximum 25.47M Dec 2011
    Average -3.287M